Trial supports glargine use in resource-limited Type 1 diabetes care
A trial led by University of Pittsburgh researchers and published today in The Lancet Diabetes & Endocrinology adds nuance…
LLY’s Oral GLP-1 Pill Foundayo Shows Heart Benefits in Diabetes Study
Eli Lilly and Company LLY announced that a phase III study, ACHIEVE-4, evaluating its newly approved oral GLP-1…